← Back to Search

Virus Therapy

Saliva Testing for Strep Throat

N/A
Recruiting
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
< 19 years of age
Able to provide a saliva sample
Must not have
Parent/guardian and/or patient unable to consent or assent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 24 hours of collection
Awards & highlights

Summary

This trial is testing if saliva can be used to diagnose GAS infection as effectively as throat swabs. They will compare different testing methods in the lab to see if faster testing methods, like molecular testing,

Who is the study for?
This study is for individuals, particularly children, who may have a streptococcal infection or strep throat. It's designed to see if saliva can be used instead of throat swabs for diagnosis. The specific eligibility criteria are not provided but would typically include having symptoms of a GAS infection.
What is being tested?
The trial is testing the effectiveness of using saliva samples to diagnose Group A Streptococcus (GAS) infections. It compares saliva sample results with traditional throat swab tests and evaluates different lab testing methods, including faster molecular techniques.
What are the potential side effects?
Since this trial involves only the collection of saliva, there are no direct side effects associated with typical drug interventions. However, participants might experience minor discomfort or anxiety during the collection process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am under 19 years old.
Select...
I can provide a saliva sample.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I or my guardian cannot give consent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 24 hours of collection
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 24 hours of collection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate and sensitivity of GAS detection

Side effects data

From 2022 Phase 2 trial • 946 Patients • NCT02821832
1%
Stab wound
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm A
Arm B
Arm C

Trial Design

1Treatment groups
Experimental Treatment
Group I: Saliva collectionExperimental Treatment1 Intervention
Self-collected saliva sample
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Saliva collection
2021
Completed Phase 2
~6010

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
704 Previous Clinical Trials
6,956,677 Total Patients Enrolled
~0 spots leftby Sep 2024